+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Aggrenox"

Global Aspirin Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Global Aspirin Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 140 Pages
  • Global
From
Aggrenox - Product Thumbnail Image

Aggrenox

  • Report
  • July 2018
  • 13 Pages
  • Global
From
Ischemic Stroke Market and Forecast Analysis 2024 - Product Thumbnail Image

Ischemic Stroke Market and Forecast Analysis 2024

  • Drug Pipelines
  • January 2019
  • 163 Pages
  • Global
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Aggrenox is a cardiovascular drug used to reduce the risk of stroke in patients who have had a transient ischemic attack (TIA) or ischemic stroke. It is a combination of two drugs, aspirin and extended-release dipyridamole, and is used to reduce the risk of recurrent stroke. Aggrenox is a prescription medication and is available in capsule form. It is typically taken twice daily with food. Aggrenox is a popular drug in the cardiovascular market, as it is effective in reducing the risk of stroke. It is also well-tolerated by most patients, with few side effects. Aggrenox is often prescribed in combination with other medications, such as anticoagulants, to further reduce the risk of stroke. Companies in the Aggrenox market include Boehringer Ingelheim, Pfizer, and Mylan. Show Less Read more